NASDAQ · Medical - Healthcare Information Services

Aclarion, Inc. (ACON) Stock

$2.34 +1.30% NASDAQ: ACON Healthcare

Valuation

MetricValue
Price$2.34
Market Cap$6.74M
P/E Ratio-0.34
P/B Ratio0.38
P/S Ratio16.49
EPS (TTM)$-13.61
52-Week High$12.03
52-Week Low$1.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-59.34%
ROA-50.98%
ROCE-57.11%
Gross Margin-50.96%
Operating Margin—
Net Margin-103.36%
Debt/Equity0.00
Current Ratio14.81

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-6.0M$-5.0M$-6.0M$-7.0M
Net Profit$-5.0M$-7.0M$-5.0M$-7.0M$-7.0M
EPS$-120035.00$-177396.00$-79782.00$-7480.21$-13.61
Op Margin-4897.9%-9201.2%-6466.5%-12057.2%-9312.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0M$3.0M$2.0M$2.0M$14.0M
Total Liabilities$8.0M$1.0M$3.0M$1.0M$1.0M
Cash$0$1.0M$1.0M$0$12.0M
Borrowings$2.0M$0$1.0M$0$0

Latest News

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice GlobeNewswire · Jul 21, 2026 Aclarion Announces Texas Spine Care Center as New CLARITY Site GlobeNewswire · Jul 7, 2026 Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub GlobeNewswire · Jun 10, 2026 Aclarion Launches Market Access Program With PRIA Healthcare MT Newswires · Jun 9, 2026 Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-5.0M$-4.0M$-5.0M$-7.0M
Investing Cash Flow$0$0$0$-1.0M$0
Financing Cash Flow$0$0$0$-1.0M$-1.0M
Net Cash Flow$0$1.0M$0$-1.0M$12.0M
Free Cash Flow$-2.0M$-5.0M$-4.0M$-6.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA1.66
FCF Yield-585.41%
Quick Ratio16.20
Interest Coverage0.00
Return 1Y-63.74%
Return 3Y-100.00%
Return 5Y—

Ownership

Insiders Held26.20%
Institutions Held4.35%
Institutions Float Held5.90%
Institutional HolderSharesReport Date
Osaic Holdings Inc.34,9452026-03-31
Geode Capital Management, LLC31,2152026-03-31
CAPTRUST Financial Advisors14,5592026-03-31
Bank of Montreal /CAN/10,0002026-03-31
UBS Group AG9,6472026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BFRGBullfrog AI Holdings, Inc. $0.65 -6.70% -1.26 $11.98M 0.00%
BNBX $0.16 +0.00% 0.00 $210492 0.00%
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CMNDClearmind Medicine Inc. $6.58 -0.30% -0.51 $1.22M 0.00%
ENSCEnsysce Biosciences, Inc. $0.53 +15.07% -0.16 $8.10M 0.00%

About Aclarion, Inc.

Aclarion, Inc. is led by CEO Brent Ness, employs 5 people, headquartered in US, publicly traded since 2022.

Aclarion, Inc. (ACON) stock trades at $2.34 with a market capitalization of $6.74M. The stock is valued at a price-to-earnings (P/E) ratio of -0.34, price-to-book of 0.38, price-to-sales of 16.49. Over the past 52 weeks the stock has ranged between $1.95 and $12.03, and currently trades 80.5% below its 52-week high.

On profitability, Aclarion, Inc. generates a return on equity (ROE) of -59.34%, return on capital employed of -57.11%, a net profit margin of -103.36%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides